Schroder Investment Management Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Hold |
45,950
| – | – | ﹤0.01% | 923 |
|
|
2025
Q1 | $1.43M | Sell |
45,950
-54,709
| -54% | -$1.7M | ﹤0.01% | 949 |
|
|
2024
Q4 | $3.52M | Buy |
100,659
+44,437
| +79% | +$1.55M | ﹤0.01% | 834 |
|
|
2024
Q3 | $2.3M | Hold |
56,222
| – | – | ﹤0.01% | 917 |
|
|
2024
Q2 | $2.68M | Sell |
56,222
-59,436
| -51% | -$2.83M | ﹤0.01% | 892 |
|
|
2024
Q1 | $5.01M | Buy |
115,658
+72,658
| +169% | +$3.15M | 0.01% | 780 |
|
|
2023
Q4 | $2.18M | Buy |
+43,000
| New | +$2.18M | ﹤0.01% | 893 |
|
|
2021
Q2 | – | Sell |
-589
| Closed | -$26K | – | 1561 |
|
|
2021
Q1 | $26K | Sell |
589
-240
| -29% | -$10.6K | ﹤0.01% | 1450 |
|
|
2020
Q4 | $47K | Sell |
829
-118
| -12% | -$6.69K | ﹤0.01% | 1394 |
|
|
2020
Q3 | $43K | Sell |
947
-325
| -26% | -$14.8K | ﹤0.01% | 1271 |
|
|
2020
Q2 | $75K | Sell |
1,272
-120
| -9% | -$7.08K | ﹤0.01% | 1168 |
|
|
2020
Q1 | $71K | Buy |
+1,392
| New | +$71K | ﹤0.01% | 1204 |
|
|
2019
Q4 | – | Sell |
-18,647
| Closed | -$1.1M | – | 1310 |
|
|
2019
Q3 | $1.1M | Buy |
+18,647
| New | +$1.1M | ﹤0.01% | 973 |
|
|
2019
Q2 | – | Sell |
-11,460
| Closed | -$930K | – | 1221 |
|
|
2019
Q1 | $930K | Sell |
11,460
-524
| -4% | -$42.5K | ﹤0.01% | 913 |
|
|
2018
Q4 | $648 | Sell |
11,984
-2,096
| -15% | -$113 | ﹤0.01% | 960 |
|
|
2018
Q3 | $726K | Buy |
+14,080
| New | +$726K | ﹤0.01% | 983 |
|
|
2017
Q4 | – | Sell |
-5,047
| Closed | -$266K | – | 1362 |
|
|
2017
Q3 | $266K | Sell |
5,047
-2,702
| -35% | -$142K | ﹤0.01% | 1164 |
|
|
2017
Q2 | $401K | Buy |
+7,749
| New | +$401K | ﹤0.01% | 1092 |
|